Impact of HIV mother-infant pair clinics on 12 month retentio

Not Applicable

• Conditions: HIV/AIDS

• Registration Number: PACTR201702001970148
• Lead Sponsor: Clinton Health Access Initiative

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-01-13
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Other
• Sex: All
• Target Recruitment: 448

Inclusion Criteria

The following will be used as inclusion criteria for the program:
¿For the retrospective study, HIV exposed infants (HEI)s will be included if they are 1) over the age of 6 weeks and under 3 months of age at 12 - 9 months before the launch of the MIP clinic program and 2) receiving services from a study facility.
¿For the prospective study, HEIs will be included if they are 1) over the age of 6 weeks and under 3 months of age at the time of the launch of the MIP clinic and 2) receiving services from a study facility.
¿For mother¿s questionnaire, women will be eligible for inclusion if they 1) are age 18 years or older, 2) are HIV-positive and 3) are receiving under-five services for their infant from a study site. At baseline, any woman meeting the other criteria and attending the under-five clinic will be eligible. At end line, women who have attended at least three Umoyo clinic days will be eligible.

Exclusion Criteria

The following will be used as exclusion criteria for the program:
¿For the retrospective study, any HEI who is under age 6 weeks or over 3 months of age at 12 -9 months before the launch of the MIP program will be excluded.
¿For the prospective study, any HEI who is under age 6 weeks or over 12 months of age at the time of the Umoyo clinic launch will be excluded. HEIs will also be excluded if they have already tested positive before age 12 months.
¿For mother¿s exit questionnaire, women will be excluded if they 1) are under 18 years, 2) are not HIV-positive or 3) do not regularly receive under-five services for their infant from a study site. At end line, women will be excluded if they have not attended at least three Umoyo clinic days.

Study & Design

• Study Type: Interventional
• Study Design: Not specified